Entrada Therapeutics

www.entradatx.com
One Design Center Place, Suite 17- 500
Boston, MA 2210

Company Info

Phone
(857) 520-9158

Year Established
2016

Ticker
TRDA

Exchange
NASDAQ

Contacts

Dipal Doshi
CEO

Natarajan Sethuraman, PhD
CSO

Nathan J. Dowden
President & COO

Kory Wentworth, CPA
CFO

Jared Cohen, PhD, JD
General Counsel

Company Description

Entrada Therapeutics is a biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines, Endosomal Escape Vehicle (EEV) therapeutics, to engage intracellular targets that have long been considered inaccessible and undruggable.

bioinnovatise accelerates scientific discovery by providing fast, reliable, and high-quality CDMO services for plasmid DNA and viral vector-based research.